Cxcr4 antagonist treatment of hematopoietic cells

Details Cxcr4 antagonist treatment of hematopoietic cells Cxcr4 antagonist treatment of hematopoietic cells

A - Human Necessities

61

K

A61K 38/04 (2006.01) A61K 35/12 (2006.01) A61K 38/10 (2006.01) A61K 38/16 (2006.01) A61K 38/17 (2006.01) A61K 38/19 (2006.01) A61K 48/00 (2006.01) C07K 14/47 (2006.01) C07K 14/52 (2006.01) C12N 5/06 (2006.01) A61K 38/00 (2006.01)

Patent

CA 2305787

In accordance with various aspects of the invention, CXCR4 antagonists may be used to treat hematopoietic cells, such as progenitor or stem cells, to increase the rate of cellular multiplication or DNA synthesis. CXCR4 antagonists may be used therapeutically to stimulate hematopoietic cell multiplication, particularly progenitor or stem cell multiplication, in human diseases such as cancer.

Affiliated with

Also associated with

Rating

Cxcr4 antagonist treatment of hematopoietic cells does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Cxcr4 antagonist treatment of hematopoietic cells, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Cxcr4 antagonist treatment of hematopoietic cells will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-1693451